Sleep Number Corp: Form 10-Q for the period ended Jun 28, 2025
Filed with the SEC on Jul 31, 2025 and accepted by EDGAR at Jul 31, 2025, 16:01 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-06-28. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-03-30 to 2025-06-28 | $327.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2024-12-29 to 2025-06-28 | $721.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-03-30 to 2025-06-28 | $134.2m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2024-12-29 to 2025-06-28 | $286.9m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2025-03-30 to 2025-06-28 | $193.7m | us-gaap:GrossProfit |
| Gross profit | 6 months2024-12-29 to 2025-06-28 | $434.3m | us-gaap:GrossProfit |
| Research and development | 3 months2025-03-30 to 2025-06-28 | $9.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2024-12-29 to 2025-06-28 | $20.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2025-03-30 to 2025-06-28 | −$75.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2024-12-29 to 2025-06-28 | $1.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2025-03-30 to 2025-06-28 | $11.7m | us-gaap:InterestExpenseNonoperating |
| Interest expense | 6 months2024-12-29 to 2025-06-28 | $22.8m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months2025-03-30 to 2025-06-28 | $13.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2024-12-29 to 2025-06-28 | $12.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-03-30 to 2025-06-28 | −$25.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2024-12-29 to 2025-06-28 | −$33.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-03-30 to 2025-06-28 | −$1.09 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2024-12-29 to 2025-06-28 | −$1.48 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-03-30 to 2025-06-28 | −$1.09 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2024-12-29 to 2025-06-28 | −$1.48 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-03-30 to 2025-06-28 | 22,903,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2024-12-29 to 2025-06-28 | 22,804,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2024-12-29 to 2025-06-28 | $1.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2024-12-29 to 2025-06-28 | $8.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2024-12-29 to 2025-06-28 | $944.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-06-28 | $1.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-06-28 | $175.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-06-28 | $804.5m | us-gaap:Assets |
| Current liabilities | At period end2025-06-28 | $903.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-06-28 | $1.29bn | us-gaap:Liabilities |
| Current portion of debt | At period end2025-06-28 | $563.9m | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2025-06-28 | −$480.7m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2025-06-28 | 22,771,000 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000827187-25-000103. Last ingested by Listed: Oct 24, 2026, 14:57 ET. Listed shows no prices and gives no investment advice.